Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Crispr Therapeutics Ag (CRSP)

Crispr Therapeutics Ag (CRSP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,647,935
  • Shares Outstanding, K 75,429
  • Annual Sales, $ 720 K
  • Annual Income, $ -348,870 K
  • 60-Month Beta 2.31
  • Price/Sales 12,115.85
  • Price/Cash Flow N/A
  • Price/Book 4.94
Trade CRSP with:

Options Overview

Details
  • Implied Volatility 80.88%
  • Historical Volatility 43.64%
  • IV Percentile 74%
  • IV Rank 28.44%
  • IV High 129.18% on 03/12/20
  • IV Low 61.68% on 05/22/20
  • Put/Call Vol Ratio 0.41
  • Today's Volume 5,577
  • Volume Avg (30-Day) 10,093
  • Put/Call OI Ratio 0.42
  • Today's Open Interest 77,607
  • Open Int (30-Day) 68,010

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -1.49
  • Number of Estimates 8
  • High Estimate -1.32
  • Low Estimate -1.64
  • Prior Year -1.15
  • Growth Rate Est. (year over year) -29.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
100.00 +13.62%
on 03/05/21
175.44 -35.24%
on 02/09/21
-55.61 (-32.86%)
since 02/08/21
3-Month
100.00 +13.62%
on 03/05/21
220.20 -48.40%
on 01/15/21
-32.85 (-22.43%)
since 12/08/20
52-Week
32.30 +251.76%
on 03/16/20
220.20 -48.40%
on 01/15/21
+62.76 (+123.40%)
since 03/06/20

Most Recent Stories

More News
CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $114.65, marking a -0.73% move from the previous day.

CRSP : 113.62 (-0.90%)
Bulls & Bears Battle It Out In Big Tech

Yields are on the rise and valuation-propelled tech is getting deflated.

TSLA : 563.00 (-5.84%)
TDOC : 176.65 (-6.87%)
SQ : 201.87 (-6.73%)
CRSP : 113.62 (-0.90%)
ROKU : 327.19 (-7.45%)
CRISPR Therapeutics to Participate in Upcoming Investor Conferences

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team...

CRSP : 113.62 (-0.90%)
CRISPR Therapeutics (CRSP) Q4 Earnings Miss, Revenues Fall Y/Y

CRISPR Therapeutics (CRSP) misses estimates for both earnings and revenues in the fourth quarter of 2020. Focus on pipeline development.

ACOR : 5.17 (-0.96%)
VRTX : 213.58 (+0.75%)
CRSP : 113.62 (-0.90%)
VCEL : 40.75 (-4.14%)
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results

- More than 20 patients have been dosed with CTX001(TM) across CLIMB-Thal-111 and CLIMB-SCD-121 to date; completion of enrollment in both trials is expected in 2021 -

CRSP : 113.62 (-0.90%)
Meridian Bioscience, CRISPR Therapeutics, Tilray and Uber highlighted as Zacks Bull and Bear of the Day

Meridian Bioscience, CRISPR Therapeutics, Tilray and Uber highlighted as Zacks Bull and Bear of the Day

VIVO : 22.13 (+1.00%)
CRSP : 113.62 (-0.90%)
TLRY : 22.42 (+3.65%)
UBER : 53.20 (-4.21%)
Bear of the Day: CRISPR Therapeutics (CRSP)

Bear of the Day: CRISPR Therapeutics (CRSP)

NTLA : 46.59 (-10.08%)
EDIT : 40.54 (-2.62%)
CRSP : 113.62 (-0.90%)
ARKK : 110.26 (-5.82%)
ARKG : 81.74 (-3.99%)
CRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should Know

CRISPR Therapeutics AG (CRSP) closed at $168.81 in the latest trading session, marking a +0.61% move from the prior day.

CRSP : 113.62 (-0.90%)
CRISPR (CRSP) to Report Q4 Earnings: What's in the Cards?

On CRISPR Therapeutics' (CRSP) fourth-quarter earnings call, investor focus will be on the company's progress with the development of its lead gene-editing candidate, CTX001.

VRTX : 213.58 (+0.75%)
SGEN : 148.68 (-0.45%)
ACAD : 45.78 (-6.53%)
CRSP : 113.62 (-0.90%)
CRISPR Therapeutics to Participate in the Guggenheim Healthcare Talks 2021 Oncology Day

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team...

CRSP : 113.62 (-0.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

CRISPR Therapeutics AG is a gene-editing company. It focused on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. CRISPR Therapeutics AG is headquartered in Basel, Switzerland.

See More

Key Turning Points

3rd Resistance Point 131.66
2nd Resistance Point 127.41
1st Resistance Point 120.51
Last Price 113.62
1st Support Level 109.36
2nd Support Level 105.11
3rd Support Level 98.21

See More

52-Week High 220.20
Fibonacci 61.8% 148.42
Fibonacci 50% 126.25
Last Price 113.62
Fibonacci 38.2% 104.08
52-Week Low 32.30

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar